No abstract available
Keywords:
EIM; IBD; markers; systemic inflammation; tailored therapy.
Grants and funding
This work was supported by the research grants of the National Research, Development and Innovation Office (Grant ID: 125377, 129266, and 134863), by the New National Excellence Program of the Ministry of Human Capacities (UNKP-20-5-SZTE-161), Janos Bolyai Research Grant (BO/00598/19/5), and the Géza Hetényi Research Grant (to AB) by the Faculty of Medicine, University of Szeged.